[5]
Sachan, R.; Parashar, T.; Singh, V.; Singh, G.; Tyagi, S.; Patel, C.; Gupta, A. Drug carrier transfersomes: A novel tool for transdermal drug delivery system. Int. J. Res. Developm. Pharma. Life Sci., 2013, 2(2), 309-316.
[6]
Punasiya, R.; Joshi, A.; Gupta, S.; Punasiya, J. Transfersomes-a novel carrier for transdermal drug delivery. Res. J. Pharm. Dos. Forms Technol., 2010, 2(2), 133-138.
[7]
Anusha, V. Transfersomes-a novel vesicular system. Res. J. Pharm. Dos. Forms Technol., 2014, 6(4), 286-291.
[9]
Pawar, A.Y. Transfersome: A novel technique which improves transdermal permeability. Asian J. Pharm., 2016, 10(04) [AJP].
[10]
Modi, C.D.; Bharadia, P.D. Transfersomes: New dominants for transdermal drug delivery. Am. J. Pharm. Tech. Res., 2012, 2(3), 71-91.
[11]
Prajapati, S.T.; Patel, C.G.; Patel, C.N. Transfersomes: A vesicular carrier system for transdermal drug delivery. Asian J. Biochem. Pharmaceut. Res., 2011, 2(1), 507-524.
[12]
Sharma, U.; Verma, P.; Jain, N.K. A review on novel vesicular drug delivery system: Transfersomes. Int. J. Pharma. Life Sci., 2020, 11(7)
[13]
Walve, J. R.; Bakliwal, S. R.; Rane, B. R.; Pawar, S. P. Transfersomes: A surrogated carrier for transdermal drug delivery system. IJABPT, 2011, 2(1), 1-10.
[27]
Li, J.; Wang, X.; Zhang, T.; Wang, C.; Huang, Z.; Luo, X.; Deng, Y. A review on phospholipids and their main applications in drug delivery systems. Asian J. Pharmaceut. Sci., 2015, 10(2), 81-98.
[30]
Ahmed, A.; Ghourab, M.; Gad, S.; Qushawy, M. The application of Plackett-Burman design and response surface methodology for optimization of formulation variables to produce Piroxicam niosomes. Int. J. Drug Dev. Res, 2013, 5(2), 121-130.
[35]
Podili, C.; Firoz, S. A review on transfersomes for transdermal drug delivery. J. Glob. Trends Pharm. Sci., 2014, 5(4), 2118-2127.
[43]
Sivannarayana, P.; Rani, A. P.; Saikishore, V. Transfersomes: Ultra deformable vesicular carrier systems in transdermal drug delivery system. Res. J. Pharm. Dos. Forms Technol., 2012, 4(5), 243-255.
[55]
Kadu, S.D.P. Transfersomes-A boon for transdermal delivery. Indo Am. J. Pharm. Sci, 2017, 4, 2908-2919.
[64]
Shaji, J.E.S.S.Y.; Lal, M.A.R.I.A. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int. J. Pharm. Pharm. Sci., 2014, 6(1), 467-477.
[66]
Darusman, F.; Raisya, R.; Priani, S.E. Development, characterization, and performance evaluation of transfersome gel of ibuprofen as a transdermal drug delivery system using nanovesicular carrier. Drug Invent. Today, 2019, 10, 3750-3755.
[69]
Zubaydah, W. O. S.; Andriani, R.; Suryani, S.; Indalifiani, A.; Jannah, S. R. N.; Hidayati, D. Optimization of soya phosphatidylcholine and tween 80 as A preparation of diclofenac sodium transfersome vesicles using design-expert. J. Farmasi Galenik., 2023, 9(1), 86-102.
[89]
Harmita, H.; Iskandarsyah, I.; Afifah, S. F. Effect of transfersome formulation on the stability and antioxidant activity of N-acetylcysteine in anti-aging cream. Int. J. Appl. Pharmaceut., 2020, 156-162.
[90]
Saraf, S.; Jeswani, G.; Kaur, C.D.; Saraf, S. Development of novel herbal cosmetic cream with Curcuma longa extract loaded transfersomes for antiwrinkle effect. Afr. J. Pharm. Pharmacol., 2011, 5(8), 1054-1062.
[93]
Bermingham, N.A; Bettencourt, B.R. Methods for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity. A.U. Patent 2022291644A1, 2023.
[94]
Joseph, J. Topical formulations containing erythritol and methods of treating skin conditions. W.O. Patent 2023009829A1, 2023.
[95]
Keneddy, J.P. Compositions for treating obesity. A.U. Patent 2023200284A1, 2023.
[96]
Keneddy, J.P. Compositions for treating dermatological diseases. A.U. Patent 2023200286A1, 2023.
[97]
Wootten, S. Biologic preserving composition and methods of use. U.S. Patent 20230018930A1, 2023.
[98]
Angelo, N.D; Weiss, M. Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth. U.S. Patent 20230000746A1, 2023.
[99]
Gupta, D.S. A system to produce acyclovir using transfersomes and to overcome the barrier function of the skin. D.E. Patent 202021106867U1, 2022.
[100]
System for developing a neem oil-loaded transethosomal gel and its composition.. D.E. Patent 202022104296U1, 2022.
[101]
Charisse, K; Kuchimanchi, S; Maier, M; Manoharan, M; Rajeev, K.G; Zimmermann, T. RNAi agents, compositions, and methods of use thereof for treating transthyretin (ttr) associated diseases. A.U. Patent 2022231749A1, 2022.
[102]
Kasperkovitz, P; Gollob, J Dosages and methods for delivering lipid formulated nucleic acid molecules. U.S. Patent 20210388355A1, 2022.
[103]
Seiberg, M. Compositions containing natural extracts and use thereof for skin and hair. A.U. Patent 2022204824A1, 2022.
[104]
Lademann, J; Meinke, M; Klein, A.L; Busch, L; Keck, C; Pelikh, O. Composition for particle-mediated transport of a dissolved active agent into hair follicles. W.O. Patent 2022268971A1, 2022.
[105]
Manca, M.L; Manconi, M; Fadda, A.M. Phospholipid three-dimensional vesicular aggregates scattered in alcoholic mixtures with no or low water content, their preparation and use in formulations for topical application. E.P. Patent 3381517B1, 2022.
[106]
Verbeck, G; Mckinley, R.S. Products of manufacture and methods for transdermal delivery of pharmaceuticals, electrolytes, and nutraceuticals. U.S. Patent 20220211638A1, 2022.
[107]
Garraway, R.W; Henry, W. Vesicles. U.S. Patent 20220031615A1, 2022.
[108]
El-Say, K.M; Al-Hejaili, O.D; Alamoudi, A.A; Ahmed, O.A.A. Transfersome-containing transdermal film formulations and methods of use. U.S. Patent 11185513B1, 2021.
[109]
Topical cetirizine 1% vs minoxidil 5% gel in treatment of androgenetic alopecia. NCT04293822, 2020.
[110]
Ketoprofen in transfersome compared to oral celecoxib and placebo for pain associated with osteoarthritis of the knee. NCT00317733, 2009.
[111]
Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric Exercise. NCT01020279, 2010.
[112]
Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee. NCT00722852, 2009.
[113]
Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA) NCT00716547, 2009.